Two types of antibodies are induced by vaccination with A/California/2009pdm virus: Binding near the sialic acid-binding pocket and neutralizing both H1N1 and H5N1 viruses

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Ohshima, Nobuko ^a   Kubota Koketsu, Ritsuko ^b   Iba, Yoshitaka ^a   Okuno, Yoshinobu ^c   Kurosawa, Yoshikazu ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE;

ANTIBODY PRODUCTION; ARTICLE; BINDING AFFINITY; CELL GROWTH; CELL SELECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION INHIBITION; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; MEMORY CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; VACCINATION; VIRUS NEUTRALIZATION;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; B-LYMPHOCYTES; BINDING SITES, ANTIBODY; EPITOPES; FEMALE; FOLLOW-UP STUDIES; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; MALE; TIME FACTORS; VACCINATION;

EID: 84895523733     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087305     Document Type: Article

References (22)

1. Skehel JJ, Wiley DC (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69: 531-569.
2. Knossow M, Gaudier M, Douglas A, Barrere B, Bizebard T et al. (2002) Mechanism of neutralization of influenza virus infectivity by antibodies. Virology 302: 294-298. (Pubitemid 35373857)
3. Okuno Y, Isegawa Y, Sasao F, Ueda S (1993) A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol 67: 2552-2558. (Pubitemid 23118850)
4. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD et al. (2009) Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324: 1557-1561.
5. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945-1952.
6. Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J et al. (2011) Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 208: 181-193.
7. Li GM, Chiu C, Wrammert J, McCausland M, Andrews SF et al. (2012) Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc Natl Acad Sci U S A 109: 9047-9052.
8. Okada J, Ohshima N, Kubota-Koketsu R, Ota S, Takase W et al. (2010) Monoclonal antibodies in man that neutralized H3N2 influenza viruses were classified into three groups with distinct strain specificity: 1968-1973, 1977-1993 and 1997-2003. Virology 397: 322-330.
9. Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD et al. (1991) By-passing immunization: Human antibodies from V-gene libraries displayed on phage. J Mol Biol 222: 581-597.
10. Iba Y, Ito W, Kurosawa Y (1997) Expression vectors for the introduction of highly diverged sequences into the six complementarity-determining regions of an antibody. Gene 194: 35-46. (Pubitemid 27312205)
11. Morino K, Katsumi H, Akahori Y, Iba Y, Shinohara M et al. (2001) Antibody fusions with fluorescent proteins: a versatile reagent for profiling protein expression. J Immunol Methods 257: 175-184.
12. Okuno Y, Tanaka K, Baba K, Maeda A, Kunita N et al. (1990) Rapid focus reduction neutralization test of influenza A and B viruses in microtiter system. J Clin Microbiol 28: 1308-13131.
13. Ito W, Kurosawa Y (1993) Development of an artificial antibody system with multiple valency using an Fv fragment fused to a fragment of protein A. J Biol Chem 268: 20668-20675. (Pubitemid 23278984)
14. Ohshima N, Iba Y, Kubota-Koketsu R, Asano Y, Okuno Y et al. (2011) Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5. J Virol 85: 11048-11057.
15. Sui J, Hwang WC, Perez S, Wei G, Aird D et al. (2009) Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16: 265-273.
16. Ekiert DC, Bhabha G, Elsliger MA, Friesen RHE, Jongeneelen M et al. (2009) Antibody recognition of a highly conserved influenza virus epitope. Science 324: 246-251.
17. Huang CC, Venturi M, Majeed S, Moore MJ, Phogat S et al. (2004) Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. Proc Natl Acad Sci U S A 101: 2706-2711. (Pubitemid 38327675)
18. Wiley DC, Wilson IA, Skehel JJ (1981) Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289: 373-378. (Pubitemid 11135143)
19. Underwood PA (1982) Mapping of antigenic changes in the Haemagglutinin of Hong Kong influenza (H3N2) strains using a large panel of monoclonal antibodies. J Gen Virol 62: 153-169.
20. Okada J, Ohshima N, Kubota-Koketsu R, Iba Y, Ota S et al. (2011) Localization of epitopes recognized by monoclonal antibodies that neutralized the H3N2 influenza viruses in man. J Gen Virol 92: 326-335.
21. Ekiert DC, Friesen RHE, Bhabha G, Kwaks T, Jongeneelen M et al. (2011) A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333: 843-850.
22. Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A et al. (2011) A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333: 850-856.